Article Information
History
- April 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pragya D. Yadav, Ph.D*,#,1,
- Gajanan N. Sapkal, Ph.D1,#,
- Priya Abraham, M.D, Ph.D1,
- Raches Ella, M.S.2,
- Gururaj Deshpande, Ph.D1,
- Deepak Y. Patil, Ph.D1,
- Dimpal A Nyayanit, Ph.D1,
- Nivedita Gupta, Ph.D.3,
- Rima R. Sahay, M.D.1,
- Anita M Shete, Ph.D1,
- Samiran Panda, M.D., Ph.D3,
- Balram Bhargava, D.M.3 and
- V. Krishna Mohan, Ph.D.2
- 1Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
- 2Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India Pin-500 078
- 3Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India Pin-110029
- ↵*Corresponding author
, Dr. Pragya D. Yadav, Scientist ‘E’ and Group Leader, Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra, India Pin-411021. Phone: +9120-26006111, Fax No. 91-20-26122669, Email: hellopragya22{at}gmail.com
↵# Equal first author
Posted April 23, 2021.
Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees
